Ranking of Increasing Margin Buying Positions in Japan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	Margin Ratio	Buy Positions(Shares)	Weekly Change	Market Cap	Liquidity
RIBOMIC 4591 TSE Growth	99	+4 +4.21%	20,657,400	0.00	8,669,300	+807,600	5.38B	Slightly High
JELLY BEANS 3070 TSE Growth	93	-10 -9.7%	7,444,800	0.00	13,358,800	+801,700	7.39B	Slightly High
Tsubota Lab 4890 TSE Growth	357	-24 -6.3%	662,300	183.72	1,267,700	+700,200	9.21B	Mid
Solasia Pharma 4597 TSE Growth	32	0 ー%	47,156,400	14.99	21,910,100	+452,900	8.63B	Mid
Noile-Immune Biotech 4893 TSE Growth	152	-29 -16%	2,851,100	0.89	1,486,600	+271,000	6.58B	Mid
Schoo 264A TSE Growth	476	-48 -9.2%	538,700	0.00	2,196,200	+141,600	6.05B	Slightly High
Neural Group 4056 TSE Growth	355	-20 -5.3%	50,000	0.00	703,500	+140,200	6.1B	Mid
Japan Hospice 7061 TSE Growth	776	-32 -4.0%	54,200	29.83	1,258,800	+127,500	6.54B	Mid
Chordia Therapeutics 190A TSE Growth	126	-2 -1.6%	2,239,900	0.00	5,437,600	+118,900	9.19B	Slightly High
PRISM BioLab 206A TSE Growth	181	-17 -8.6%	783,400	1,341.29	1,877,800	+114,000	6.69B	Slightly High
Premier Anti-Aging 4934 TSE Growth	620	-28 -4.3%	225,900	3.97	301,300	+106,400	5.41B	Mid
Brains Technology 4075 TSE Growth	1,667	-194 -10%	569,400	1,741.00	174,100	+90,200	9.94B	Mid
SpiderPlus 4192 TSE Growth	251	-9 -3.5%	175,400	1.41	1,081,000	+62,300	8.91B	Mid
Chiome Bioscience 4583 TSE Growth	107	-5 -4.5%	1,004,300	0.00	5,875,200	+52,500	7.43B	Mid
toridori 9337 TSE Growth	1,594	-86 -5.1%	23,000	0.00	326,400	+34,800	5.26B	Mid
NAKAMURA CHOUKOU 6166 TSE Growth	785	-13 -1.6%	258,200	5,063.50	1,012,700	+32,300	8.65B	Slightly High
LaKeel 4074 TSE Growth	665	-12 -1.8%	41,700	1.89	176,400	+28,800	5.1B	Mid
Writeup 6580 TSE Growth	1,613	-80 -4.7%	47,600	74.21	423,000	+28,700	9.37B	Mid
Carna Biosciences 4572 TSE Growth	351	-14 -3.8%	205,900	0.00	1,845,800	+28,700	6.74B	Slightly High
Wagokoro 9271 TSE Growth	990	-55 -5.3%	80,300	0.00	413,500	+27,500	6.45B	Mid

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels